Journal of Affective Disorders
Volume 86, Issue 1 , Pages 99-104 , May 2005

Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors

Received 23 September 2004 ,Accepted 29 November 2004.

References 

  1. Adson DE, Kushner MG, Eiben KM, Schulz C. Preliminary experience with adjunctive quetiapine in patients on selective serotonin reuptake inihibitors. Depress. Anxiety. 2004;19:121–126
  2. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed. Rev.. Washington, DC: Author; 2000;
  3. Barbee JG, Conrad EJ, Jamhour NJ. The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder. J. Clin. Psychiatry. 2004;65:975–981
  4. Dube S, Corya SA, Andersen S, Detke H, Blansette S, Tollefson GD. Efficacy of Olanzapine/Fluoxetine combination in treatment-resistant depression. San Juan, Puerto Rico: Poster, American College of Neuropsychopharmacology; 2002;
  5. Goodnick PJ, Jerry JM. Aripiprazole: profile on efficacy and safety. Expert Opin. Pharmacother. 2002;3(12):1773–1781
  6. Gorman J, Shear K, Cowley D, Cross CD, March J, Roth W. Practice guidelines for the treatment of patients with panic disorder. Am. J. Psychiatry. 1998;155(5):1–33
  7. Hirose S, Ashby CR. An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy. J. Clin. Psychiatry. 2002;63(8):733–736
  8. Karasu TB, Gelenberg A, Merriam A, Wang P. Practice guideline for the treatment of patients with major depressive disorder (revision). Am. J. Psychiatry. 2000;157(4):1–45
  9. Keck PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am. J. Psychiatry. 2003;160:1651–1658
  10. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch. Gen. Psychiatry. 1994;51:8–19
  11. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105
  12. Krueger RF, Piasecki TM. Toward a dimensional and psychometrically-informed approach to conceptualizing psychopathology. Behav. Res. Ther. 2002;40:485–499
  13. Menza M, Marin H, Opper RS. Residual symptoms in depression: can treatment by symptom-specific?. J. Clin. Psychiatry. 2003;64:516–523
  14. Papakostas GI, Petersen TJ, Nierenberg AA, Murakami JL, Alpert IE, Rosenbaum IF, et al. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder. J. Clin. Psychiatry. 2004;65(2):217–221
  15. Perugi G, Akiskal HS, Ramacciotti S, Nassini S, Toni C, Milanfranchi A, et al. Depressive comorbidity of panic, social phobic, and obsessive–compulsive disorders re-examined: is there a bipolar II connection?. J. Psy. Res. 1999;33(1):53–61
  16. Physicians desk reference (PDR). 58th edition. Montvale, NJ: Thomson Healthcare; 2004;
  17. Rapaport MH. Prevalence, recognition, and treatment of comorbid depression and anxiety. J. Clin. Psychiatry. 2001;62:6–10
  18. Stahl SM. Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. J. Clin. Psychiatry. 2002;63(9):756–757
  19. Stein DJ, Westenberg HG, Liebowitz MR. Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J. Clin. Psychiatry. 2002;63:12–19
  20. Thase M. Effectiveness of antidepressants: comparative remission rates. J. Clin. Psychiatry. 2003;64(2):3–7
  21. Yonkers KA, Bruce SE, Dyck IR, Keller MB. Chronicity, relapse, and illness-course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depress. Anxiety. 2003;17(3):173–179

PII: S0165-0327(04)00435-5

doi: 10.1016/j.jad.2004.11.007

Journal of Affective Disorders
Volume 86, Issue 1 , Pages 99-104 , May 2005

Article Tools

* Image Usage & Resolution